The Making of a CYP3A Biomarker Panel for Guiding Drug Therapy
CYP3A ranks among the most abundant cytochrome P450 enzymes in the liver, playing a dominant role in metabolic elimination of clinically used drugs. A main member in CYP3A family, CYP3A4 expression and activity vary considerably among individuals, attributable to genetic and non-genetic factors, aff...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
MDPI
2012
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901424/ |